Enda Adjust Glucocorticoid Clinical Response

---
name: enda-adjust-glucocorticoid-clinical-response
description: The Endocrine Society guideline recommends against routine hormonal monitoring of glucocorticoid replacement in primary adrenal insufficiency and advises adjusting therapy solely based on clinical response. Use when evaluating glucocorticoid dose adequacy, such as when patients report fatigue, weight loss, hypotension, or signs of Cushingoid over-replacement.
---

# Adjust Glucocorticoid Treatment Based Solely on Clinical Response

## STEP 1 — Gather Information
Collect clinical symptoms and signs of glucocorticoid over- or under-replacement: weight change, appetite, energy levels, blood pressure, peripheral edema, hyperpigmentation, and patient-reported well-being.

## STEP 2 — Rule In / Rule Out
Is there clinical evidence of glucocorticoid excess or deficiency? If yes, proceed to classification; if no, maintain current dose and reassess in 4–6 weeks.

## STEP 3 — Classify or Stratify
Classify as over-replacement (Cushingoid signs: weight gain, insomnia, peripheral edema, etc.), under-replacement (fatigue, weight loss, hypotension, hyperpigmentation, etc.), or adequate (stable weight, normal energy, no symptoms).

## STEP 4 — Decide
If over-replacement, reduce glucocorticoid dose by 2.5–5 mg hydrocortisone equivalent; if under-replacement, increase dose by 2.5–5 mg; if adequate, continue current regimen.

## Clinical Guardrails / Mimics / Pitfalls
Do not rely on ACTH or cortisol levels to guide dosing; avoid over-reliance on hormonal monitoring. Symptoms can be nonspecific—consider concurrent illness, stress, or pregnancy. Avoid abrupt dose changes; taper adjustments. Monitor for signs of adrenal crisis during dose reduction.

## Concrete Clinical Example
A 48-year-old man on hydrocortisone 15 mg daily reports progressive fatigue and 3 kg weight loss over 2 months, with postural hypotension; no Cushingoid signs. Clinical assessment suggests under-replacement; dose increased to 20 mg daily, with symptom reassessment scheduled in 4 weeks.

**Source:** Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI: 10.1210/jc.2015-1710